APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Drug-Eluting Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-Drug-Eluting Devices Market Outlook and Growth Opportunities 2026

27 December 2025195 pages

Choose your research edition.

Industry ResearchNon-Drug-Eluting Devices Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Drug-Eluting Devices Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Non-Drug-Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Drug-Eluting Devices Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Drug-Eluting Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non-Drug-Eluting Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-Drug-Eluting Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-Drug-Eluting Devices market include Teleflex Incorporated, Johnson & Johnson, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Stryker Corporation, Smith & Nephew plc., Peter Surgical and Integra Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-Drug-Eluting Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Drug-Eluting Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Drug-Eluting Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Drug-Eluting Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Drug-Eluting Devices Segment by Company

Teleflex Incorporated

Johnson & Johnson

Medtronic

Boston Scientific Corporation

B. Braun Melsungen AG

Stryker Corporation

Smith & Nephew plc.

Peter Surgical

Integra Lifesciences

DemeTECH Corporation

ConMed Corporation

Non-Drug-Eluting Devices Segment by Type

Implants

Sutures

Non-Drug-Eluting Devices Segment by Application

Hospital

Ambulatory Surgical Centers

Non-Drug-Eluting Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-Drug-Eluting Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-Drug-Eluting Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-Drug-Eluting Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Non-Drug-Eluting Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Drug-Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Drug-Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Drug-Eluting Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Drug-Eluting Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-Drug-Eluting Devices industry.

Chapter 3: Detailed analysis of Non-Drug-Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-Drug-Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-Drug-Eluting Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-Drug-Eluting Devices Industry Trends Table 2. Non-Drug-Eluting Devices Industry Drivers Table 3. Non-Drug-Eluting Devices Industry Opportunities and Challenges Table 4. Non-Drug-Eluting Devices Industry Restraints Table 5. Global Non-Drug-Eluting Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-Drug-Eluting Devices Revenue Share by Company (2021-2026) Table 7. Global Non-Drug-Eluting Devices Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Non-Drug-Eluting Devices Sales Volume Share by Company (2021-2026) Table 9. Global Non-Drug-Eluting Devices Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Non-Drug-Eluting Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-Drug-Eluting Devices Key Company Manufacturing Base & Headquarters Table 12. Global Non-Drug-Eluting Devices Company, Product Type & Application Table 13. Global Non-Drug-Eluting Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Implants Table 18. Significant Companies of Sutures Table 19. Global Non-Drug-Eluting Devices Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Non-Drug-Eluting Devices Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Non-Drug-Eluting Devices Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Non-Drug-Eluting Devices Sales Volume Share by Type (2021-2026) Table 23. Global Non-Drug-Eluting Devices Sales Volume Share by Type (2027-2032) Table 24. Global Non-Drug-Eluting Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Non-Drug-Eluting Devices Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Non-Drug-Eluting Devices Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Non-Drug-Eluting Devices Sales Value Share by Type (2021-2026) Table 28. Global Non-Drug-Eluting Devices Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Ambulatory Surgical Centers Table 31. Global Non-Drug-Eluting Devices Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Non-Drug-Eluting Devices Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Non-Drug-Eluting Devices Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Non-Drug-Eluting Devices Sales Volume Share by Application (2021-2026) Table 35. Global Non-Drug-Eluting Devices Sales Volume Share by Application (2027-2032) Table 36. Global Non-Drug-Eluting Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Non-Drug-Eluting Devices Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Non-Drug-Eluting Devices Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Non-Drug-Eluting Devices Sales Value Share by Application (2021-2026) Table 40. Global Non-Drug-Eluting Devices Sales Value Share by Application (2027-2032) Table 41. Global Non-Drug-Eluting Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Non-Drug-Eluting Devices Sales by Region (2021-2026) & (K Units) Table 43. Global Non-Drug-Eluting Devices Sales Market Share by Region (2021-2026) Table 44. Global Non-Drug-Eluting Devices Sales by Region (2027-2032) & (K Units) Table 45. Global Non-Drug-Eluting Devices Sales Market Share by Region (2027-2032) Table 46. Global Non-Drug-Eluting Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Non-Drug-Eluting Devices Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Non-Drug-Eluting Devices Sales Value Share by Region (2021-2026) Table 49. Global Non-Drug-Eluting Devices Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Non-Drug-Eluting Devices Sales Value Share by Region (2027-2032) Table 51. Global Non-Drug-Eluting Devices Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Non-Drug-Eluting Devices Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Non-Drug-Eluting Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Non-Drug-Eluting Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 56. Global Non-Drug-Eluting Devices Sales Market Share by Country (2021-2026) Table 57. Global Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 58. Global Non-Drug-Eluting Devices Sales Market Share by Country (2027-2032) Table 59. Global Non-Drug-Eluting Devices Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Non-Drug-Eluting Devices Sales Value Market Share by Country (2021-2026) Table 61. Global Non-Drug-Eluting Devices Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Non-Drug-Eluting Devices Sales Value Market Share by Country (2027-2032) Table 63. Teleflex Incorporated Company Information Table 64. Teleflex Incorporated Business Overview Table 65. Teleflex Incorporated Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio Table 67. Teleflex Incorporated Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Medtronic Company Information Table 74. Medtronic Business Overview Table 75. Medtronic Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Medtronic Non-Drug-Eluting Devices Product Portfolio Table 77. Medtronic Recent Development Table 78. Boston Scientific Corporation Company Information Table 79. Boston Scientific Corporation Business Overview Table 80. Boston Scientific Corporation Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio Table 82. Boston Scientific Corporation Recent Development Table 83. B. Braun Melsungen AG Company Information Table 84. B. Braun Melsungen AG Business Overview Table 85. B. Braun Melsungen AG Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio Table 87. B. Braun Melsungen AG Recent Development Table 88. Stryker Corporation Company Information Table 89. Stryker Corporation Business Overview Table 90. Stryker Corporation Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Stryker Corporation Non-Drug-Eluting Devices Product Portfolio Table 92. Stryker Corporation Recent Development Table 93. Smith & Nephew plc. Company Information Table 94. Smith & Nephew plc. Business Overview Table 95. Smith & Nephew plc. Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio Table 97. Smith & Nephew plc. Recent Development Table 98. Peter Surgical Company Information Table 99. Peter Surgical Business Overview Table 100. Peter Surgical Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Peter Surgical Non-Drug-Eluting Devices Product Portfolio Table 102. Peter Surgical Recent Development Table 103. Integra Lifesciences Company Information Table 104. Integra Lifesciences Business Overview Table 105. Integra Lifesciences Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio Table 107. Integra Lifesciences Recent Development Table 108. DemeTECH Corporation Company Information Table 109. DemeTECH Corporation Business Overview Table 110. DemeTECH Corporation Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio Table 112. DemeTECH Corporation Recent Development Table 113. ConMed Corporation Company Information Table 114. ConMed Corporation Business Overview Table 115. ConMed Corporation Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. ConMed Corporation Non-Drug-Eluting Devices Product Portfolio Table 117. ConMed Corporation Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Non-Drug-Eluting Devices Distributors List Table 121. Non-Drug-Eluting Devices Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Non-Drug-Eluting Devices Product Image Figure 2. Global Non-Drug-Eluting Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Drug-Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-Drug-Eluting Devices Sales (2021-2032) & (K Units) Figure 5. Global Non-Drug-Eluting Devices Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Non-Drug-Eluting Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Implants Image Figure 10. Sutures Image Figure 11. Global Non-Drug-Eluting Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Non-Drug-Eluting Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Non-Drug-Eluting Devices Sales Volume Share by Type (2021-2032) Figure 14. Global Non-Drug-Eluting Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Non-Drug-Eluting Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Non-Drug-Eluting Devices Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Ambulatory Surgical Centers Image Figure 19. Global Non-Drug-Eluting Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Non-Drug-Eluting Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Non-Drug-Eluting Devices Sales Volume Share by Application (2021-2032) Figure 22. Global Non-Drug-Eluting Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Non-Drug-Eluting Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Non-Drug-Eluting Devices Sales Value Share by Application (2021-2032) Figure 25. Global Non-Drug-Eluting Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Non-Drug-Eluting Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Non-Drug-Eluting Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Non-Drug-Eluting Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Non-Drug-Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 30. North America Non-Drug-Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Non-Drug-Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Non-Drug-Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Non-Drug-Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Non-Drug-Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Non-Drug-Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 36. South America Non-Drug-Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Non-Drug-Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Non-Drug-Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Non-Drug-Eluting Devices Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Non-Drug-Eluting Devices Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Implants
  • Sutures
Applications
  • Hospital
  • Ambulatory Surgical Centers
Companies covered
  • Teleflex Incorporated
  • Johnson & Johnson
  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Smith & Nephew plc.
  • Peter Surgical
  • Integra Lifesciences
  • DemeTECH Corporation
  • ConMed Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-Drug-Eluting Devices Sales Value (2021-2032)
  4. 1.2.2 Global Non-Drug-Eluting Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Non-Drug-Eluting Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-Drug-Eluting Devices Market Dynamics
  1. 2.1 Non-Drug-Eluting Devices Industry Trends
  2. 2.2 Non-Drug-Eluting Devices Industry Drivers
  3. 2.3 Non-Drug-Eluting Devices Industry Opportunities and Challenges
  4. 2.4 Non-Drug-Eluting Devices Industry Restraints
3 Non-Drug-Eluting Devices Market by Company
  1. 3.1 Global Non-Drug-Eluting Devices Company Revenue Ranking in 2025
  2. 3.2 Global Non-Drug-Eluting Devices Revenue by Company (2021-2026)
  3. 3.3 Global Non-Drug-Eluting Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-Drug-Eluting Devices Average Price by Company (2021-2026)
  5. 3.5 Global Non-Drug-Eluting Devices Company Ranking (2024-2026)
  6. 3.6 Global Non-Drug-Eluting Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-Drug-Eluting Devices Company Product Type and Application
  8. 3.8 Global Non-Drug-Eluting Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-Drug-Eluting Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-Drug-Eluting Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-Drug-Eluting Devices Market by Type
  1. 4.1 Non-Drug-Eluting Devices Type Introduction
  2. 4.1.1 Implants
  3. 4.1.2 Sutures
  4. 4.2 Global Non-Drug-Eluting Devices Sales Volume by Type
  5. 4.2.1 Global Non-Drug-Eluting Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-Drug-Eluting Devices Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Non-Drug-Eluting Devices Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Non-Drug-Eluting Devices Sales Value by Type
  9. 4.3.1 Global Non-Drug-Eluting Devices Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Non-Drug-Eluting Devices Sales Value by Type (2021-2032)
  11. 4.3.3 Global Non-Drug-Eluting Devices Sales Value Share by Type (2021-2032)
5 Non-Drug-Eluting Devices Market by Application
  1. 5.1 Non-Drug-Eluting Devices Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Ambulatory Surgical Centers
  4. 5.2 Global Non-Drug-Eluting Devices Sales Volume by Application
  5. 5.2.1 Global Non-Drug-Eluting Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non-Drug-Eluting Devices Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Non-Drug-Eluting Devices Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Non-Drug-Eluting Devices Sales Value by Application
  9. 5.3.1 Global Non-Drug-Eluting Devices Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Non-Drug-Eluting Devices Sales Value by Application (2021-2032)
  11. 5.3.3 Global Non-Drug-Eluting Devices Sales Value Share by Application (2021-2032)
6 Non-Drug-Eluting Devices Regional Sales and Value Analysis
  1. 6.1 Global Non-Drug-Eluting Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Drug-Eluting Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Non-Drug-Eluting Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Non-Drug-Eluting Devices Sales by Region (2027-2032)
  5. 6.3 Global Non-Drug-Eluting Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-Drug-Eluting Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-Drug-Eluting Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-Drug-Eluting Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Non-Drug-Eluting Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-Drug-Eluting Devices Sales Value (2021-2032)
  12. 6.6.2 North America Non-Drug-Eluting Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-Drug-Eluting Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Non-Drug-Eluting Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-Drug-Eluting Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-Drug-Eluting Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-Drug-Eluting Devices Sales Value (2021-2032)
  21. 6.9.2 South America Non-Drug-Eluting Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-Drug-Eluting Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-Drug-Eluting Devices Sales Value Share by Country, 2025 VS 2032
7 Non-Drug-Eluting Devices Country-level Sales and Value Analysis
  1. 7.1 Global Non-Drug-Eluting Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-Drug-Eluting Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-Drug-Eluting Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Non-Drug-Eluting Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Non-Drug-Eluting Devices Sales by Country (2027-2032)
  6. 7.4 Global Non-Drug-Eluting Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-Drug-Eluting Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-Drug-Eluting Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-Drug-Eluting Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-Drug-Eluting Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-Drug-Eluting Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teleflex Incorporated
  2. 8.1.1 Teleflex Incorporated Company Information
  3. 8.1.2 Teleflex Incorporated Business Overview
  4. 8.1.3 Teleflex Incorporated Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio
  6. 8.1.5 Teleflex Incorporated Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Non-Drug-Eluting Devices Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Boston Scientific Corporation
  20. 8.4.1 Boston Scientific Corporation Company Information
  21. 8.4.2 Boston Scientific Corporation Business Overview
  22. 8.4.3 Boston Scientific Corporation Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio
  24. 8.4.5 Boston Scientific Corporation Recent Developments
  25. 8.5 B. Braun Melsungen AG
  26. 8.5.1 B. Braun Melsungen AG Company Information
  27. 8.5.2 B. Braun Melsungen AG Business Overview
  28. 8.5.3 B. Braun Melsungen AG Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio
  30. 8.5.5 B. Braun Melsungen AG Recent Developments
  31. 8.6 Stryker Corporation
  32. 8.6.1 Stryker Corporation Company Information
  33. 8.6.2 Stryker Corporation Business Overview
  34. 8.6.3 Stryker Corporation Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Stryker Corporation Non-Drug-Eluting Devices Product Portfolio
  36. 8.6.5 Stryker Corporation Recent Developments
  37. 8.7 Smith & Nephew plc.
  38. 8.7.1 Smith & Nephew plc. Company Information
  39. 8.7.2 Smith & Nephew plc. Business Overview
  40. 8.7.3 Smith & Nephew plc. Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio
  42. 8.7.5 Smith & Nephew plc. Recent Developments
  43. 8.8 Peter Surgical
  44. 8.8.1 Peter Surgical Company Information
  45. 8.8.2 Peter Surgical Business Overview
  46. 8.8.3 Peter Surgical Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Peter Surgical Non-Drug-Eluting Devices Product Portfolio
  48. 8.8.5 Peter Surgical Recent Developments
  49. 8.9 Integra Lifesciences
  50. 8.9.1 Integra Lifesciences Company Information
  51. 8.9.2 Integra Lifesciences Business Overview
  52. 8.9.3 Integra Lifesciences Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio
  54. 8.9.5 Integra Lifesciences Recent Developments
  55. 8.10 DemeTECH Corporation
  56. 8.10.1 DemeTECH Corporation Company Information
  57. 8.10.2 DemeTECH Corporation Business Overview
  58. 8.10.3 DemeTECH Corporation Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio
  60. 8.10.5 DemeTECH Corporation Recent Developments
  61. 8.11 ConMed Corporation
  62. 8.11.1 ConMed Corporation Company Information
  63. 8.11.2 ConMed Corporation Business Overview
  64. 8.11.3 ConMed Corporation Non-Drug-Eluting Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ConMed Corporation Non-Drug-Eluting Devices Product Portfolio
  66. 8.11.5 ConMed Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-Drug-Eluting Devices Value Chain Analysis
  2. 9.1.1 Non-Drug-Eluting Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-Drug-Eluting Devices Sales Mode & Process
  6. 9.2 Non-Drug-Eluting Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-Drug-Eluting Devices Distributors
  9. 9.2.3 Non-Drug-Eluting Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst